Article

Proper eye care improves quality of life for the elderly

Birmingham, AL-It may seem obvious to most that nursing home residents with proper eyeglasses enjoy life more and are less depressed than those with uncorrected vision problems. However, nursing home residents have 3 to 15 times higher rates of uncorrected vision impairment than seniors living independently.

Birmingham, AL-It may seem obvious to most that nursing home residents with proper eyeglasses enjoy life more and are less depressed than those with uncorrected vision problems. However, nursing home residents have 3 to 15 times higher rates of uncorrected vision impairment than seniors living independently.

"Some of the people had no glasses at all," said Cynthia Owsley, PhD, a professor of ophthalmology at the University of Alabama, Birmingham, who led research on 150 nursing home residents. "Some had glasses at one time, but they got lost. And some had glasses but the wrong prescription."

Vision was tested and corrected immediately for half of the group and then both groups were tested 2 months later for depression. The second half was then tested and had their vision corrected.

According to Dr. Owsley those who received glasses did better on follow up, reporting much less difficulty reading, looking at magazines, playing cards, watching television, and reading a clock. They also had less psychological distress and were more socially interactive.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.